Globocare Pharmaceuticals Private Limited Company Logo

Globocare Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Pachim Vihar, Delhi, India, established in 2012.

2012 | Pachim Vihar, Delhi, India | Active
Last Updated:

About Globocare Pharmaceuticals Private Limited

Globocare Pharmaceuticals Private Limited, a active private limited company, was established on 30 May 2012 in Pachim Vihar, Delhi, India. Engaging in medicinal chemical & botanical products within the manufacturing sector, it holds CIN: U24232DL2012PTC236710. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Nibha Rani (Director), Reena Singh (Director). Past directors included Ritendra Kumar. It holds ₹0.62 M open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 68, 2Nd Floor Avtar Enclave, Pachim Vihar, Delhi, 110063.

Company Details

  • CIN/LLPIN

    U24232DL2012PTC236710

  • Registration Number

    236710

  • Incorporation Date

    30 May 2012

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 6 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 0.62 M
  • Revenue Growth -16.24%
  • Profit Growth -19.19%
  • Ebitda 15.73%
  • Net Worth 16.64%
  • Total Assets 15.11%
Company report

Globocare Pharmaceuticals Private Limited

Company Report FY 2025-2026

Explore comprehensive insights into Globocare Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element

Who are the key members and board of directors at Globocare Pharmaceuticals Private Limited?

Current Directors

NameDesignationAppointment DateStatus
Nibha RaniDirector30 May 2012Current
Reena SinghDirector30 Jan 2019Current

Past Directors

NameDesignationCessationStatus
Pramod AbcsddDirector08 Mar 2019Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Globocare Pharmaceuticals.

Globocare Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 16.24% decrease. The company also saw a substantial fall in profitability, with a 19.19% decrease in profit. The company's net worth Soared by an impressive increase of 16.64%.

Globocare Pharmaceuticals revenue growth over time
Globocare Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-16.24%
Revenue from Operations
-16.24%
Total Assets
15.11%
Profit or Loss
-19.19%
Net Worth
16.64%
EBITDA
15.73%

What is the Ownership and Shareholding Structure of Globocare Pharmaceuticals?

In 2017, Globocare Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹615,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Vijaya Bank : 0.06 Cr

Latest Charge Details

DateLenderAmountStatus
02 Jan 2019Vijaya Bank₹0.62 MOpen

Explore comprehensive loan charge details -

How Many Employees Work at Globocare Pharmaceuticals?

Unlock and access historical data on people associated with Globocare Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Globocare Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Globocare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Globocare Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Globocare Pharmaceuticals

Recent Activity within the Organization

  • Annual General Meeting

    The activity Globocare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Globocare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was completed.

  • Director Appointment

    Reena Singh was appointed as a Director was appointed as a Director on 30 Jan 2019 & has been associated with this company since 6 years 10 months . was recorded as a recent event.

  • Charges

    A charge with Vijaya Bank amounted to Rs. 0.62 M with Charge ID 100241076 was registered on 02 Jan 2019. was recorded as a recent event.

  • Director Appointment

    Nibha Rani was appointed as a Director was appointed as a Director on 30 May 2012 & has been associated with this company since 13 years 6 months . was recorded as a recent event.

  • Company Incorporation

    Globocare Pharmaceuticals Private Limited was registered on 30 May 2012 with Roc Delhi & aged 13 years 6 months as per MCA records. was recorded as a recent event.

Frequently Asked Questions

  • What is the CIN of Globocare Pharmaceuticals Private Limited?

    The CIN of Globocare Pharmaceuticals Private Limited is U24232DL2012PTC236710.

  • Where is Globocare Pharmaceuticals Private Limited headquartered?

    Globocare Pharmaceuticals Private Limited is headquartered at 68, 2Nd Floor Avtar Enclave, Pachim Vihar, Delhi, 110063.

  • When was Globocare Pharmaceuticals Private Limited incorporated?

    Globocare Pharmaceuticals Private Limited was incorporated on 30 May 2012.

  • Who are the current directors of Globocare Pharmaceuticals Private Limited?

    The current directors of Globocare Pharmaceuticals Private Limited are

  • What is the primary industry of Globocare Pharmaceuticals Private Limited?

    The primary industry of Globocare Pharmaceuticals Private Limited is Manufacturing.

  • Is Globocare Pharmaceuticals Private Limited a listed company?

    Globocare Pharmaceuticals Private Limited is unlisted.

  • What is the capital structure of Globocare Pharmaceuticals Private Limited?

    The authorized capital of Globocare Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

  • What is the compliance status of Globocare Pharmaceuticals Private Limited?

    The compliance status of Globocare Pharmaceuticals Private Limited is Compliant.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial